Showing results (471-480 of 536) with videos related to

Sort By:
Pageof 54
European Journal of Haematology|November 18, 2024
Safety and Efficacy of Teclistamab in Patients With Relapsed or Refractory AL AmyloidosisMargaret Stalker, Alfred Garfall, Adam Cohen, et al.
DNA and Cell Biology|August 1, 1994
Rat liver cytochrome P450 2B3: structure of the CYP2B3 gene and immunological identification of a constitutive P450 2B3-like protein in rat liverA Jean, A Reiss, M Desrochers, et al.
The Journal of Biological Chemistry|June 25, 1990
Cytochrome P-450-dependent oxidation of arachidonic acid to 16-, 17-, and 18-hydroxyeicosatetraenoic acidsJ R Falck, S Lumin, I Blair, et al.
American Journal of Clinical Oncology|January 1, 1988
The clinical and endocrine assessment of three different antiandrogen regimens combined with a very long-acting gonadotrophin-releasing hormone analogueJ Waxman, G Williams, J Sandow, et al.
Physiological Genomics|May 31, 2007
Role of STAT5a in regulation of sex-specific gene expression in female but not male mouse liver revealed by microarray analysisKarl H Clodfelter, Gregory D Miles, Valerie Wauthier, et al.
The Journal of Clinical Investigation|January 1, 1986
Differential binding of immunoglobulin A and immunoglobulin G1 immune complexes to primate erythrocytes in vivo. Immunoglobulin A immune complexes bind less well to erythrocytes and are preferentially deposited in glomeruliF J Waxman, L A Hebert, F G Cosio, et al.
Endocrinology|May 5, 2026
Disease-associated mutations in the STAT5B SH2 domain reprogram hepatic cholesterol and lipid metabolismHye Kyung Lee, Maxim Pyatkov, Oksana Gavrilova, et al.
Biorxiv : the Preprint Server for Biology|December 12, 2025
Disease-associated mutations in the STAT5B SH2 domain reprogram hepatic cholesterol and lipid metabolismHye Kyung Lee, Maxim Pyatkov, Oksana Gavrilova, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|April 9, 2004
trans-activation of PPARalpha and induction of PPARalpha target genes by perfluorooctane-based chemicalsJonathan M Shipley, Christopher H Hurst, Sue S Tanaka, et al.
International Journal of Cancer|August 29, 2013
Lymphokine-activated killer and dendritic cell carriage enhances oncolytic reovirus therapy for ovarian cancer by overcoming antibody neutralization in ascitesV A Jennings, E J Ilett, K J Scott, et al.
Pageof 54